Product Program year 2020 Source: CMS Open Payments

Penta SCS Leads

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$337,766

1,509 payments

Research payments

$0

0 payments

Through program year 2020, $337,766 in general payments and $0 in research payments were reported against Penta SCS Leads (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $318,307 773
2019 General $19,459 736

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $337,766 1,509 payments
Top recipients General payments · program year 2020
  1. Claudio Feler Neurological Surgery · Cheyenne, WY $294,170 92% · 2 payments
  2. Jason Garber Neurological Surgery · Las Vegas, NV $1,384 <1% · 23 payments
  3. Hashim Qureshi Pain Medicine · N Las Vegas, NV $871 <1% · 6 payments
  4. James Forage Neurological Surgery · Henderson, NV $778 <1% · 21 payments
  5. Mark Chmiela Anesthesiology · Cleveland, OH $589 <1% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Neurological Surgery $299,406 94% · 70 practitioners
  2. Pain Medicine Anesthesiology $5,171 2% · 61 practitioners
  3. Interventional Pain Medicine Pain Medicine $3,559 1% · 55 practitioners
  4. Anesthesiology $2,530 <1% · 26 practitioners
  5. Orthopaedic Surgery of the Spine Orthopaedic Surgery $2,016 <1% · 19 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Wyoming $294,170 92% · 1 recipient
  2. California $5,186 2% · 52 recipients
  3. Nevada $3,522 1% · 13 recipients
  4. Texas $2,504 <1% · 53 recipients
  5. Pennsylvania $1,597 <1% · 34 recipients

The top 5 of 36 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,509 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record